Allianz Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-38,660
| Closed | -$321K | – | 2021 |
|
|
2019
Q4 | $321K | Sell |
38,660
-103,991
| -73% | -$863K | ﹤0.01% | 2026 |
|
|
2019
Q3 | $1.07M | Sell |
142,651
-38,002
| -21% | -$284K | ﹤0.01% | 1666 |
|
|
2019
Q2 | $2.03M | Sell |
180,653
-152,747
| -46% | -$1.71M | ﹤0.01% | 1541 |
|
|
2019
Q1 | $3.58M | Buy |
333,400
+32,274
| +11% | +$347K | ﹤0.01% | 1365 |
|
|
2018
Q4 | $4.54M | Sell |
301,126
-145,097
| -33% | -$2.19M | 0.01% | 1195 |
|
|
2018
Q3 | $8.26M | Buy |
446,223
+92,693
| +26% | +$1.71M | 0.01% | 1095 |
|
|
2018
Q2 | $8.08M | Buy |
353,530
+294,791
| +502% | +$6.74M | 0.01% | 1041 |
|
|
2018
Q1 | $1.67M | Buy |
58,739
+4,036
| +7% | +$115K | ﹤0.01% | 1565 |
|
|
2017
Q4 | $1.16M | Sell |
54,703
-85
| -0.2% | -$1.8K | ﹤0.01% | 1690 |
|
|
2017
Q3 | $995K | Buy |
+54,788
| New | +$995K | ﹤0.01% | 1716 |
|